TL;DR: I asked whether the world needed brand thirty-thousand-and-one. The answer was yes, but only if we built differently. Here's what we landed on, and why.
Quick answer
There are thirty thousand skincare brands in the world. We started Elelaf because the microbiome science, the regenerative biotech, and the cortisol-skin axis weren’t being treated as foundations in most US brands — they were being treated as marketing. Here’s what we built, and why.
Why we started
There are thirty thousand skincare brands in the world. Before we started Elelaf, the honest question we asked ourselves was whether the world needed one more.
The answer we landed on, after working through it for longer than I expected to: yes, but only if we built differently than what was already there. That qualifier matters. Plenty of brands launch because the founders fall in love with packaging or a single hero ingredient or a story they want to tell. We didn’t want to be one of those.
Three things shaped the decision.
The first was the microbiome. The science has been moving fast, and most of the brands that mentioned it were treating it as a marketing layer rather than a foundation. The interesting work was happening in Korean labs, and most of it wasn’t reaching the US market in any meaningful way. There was a real gap between what we know about skin in 2026 and what most US shelves reflect.
The second was the unproductive split between “natural” and “effective.” For years, marketing pushed one or the other, as if they couldn’t coexist. The reality, when you sit with formulators, is that good skincare uses well-formulated ingredients at evidence-based concentrations, and whether each ingredient is technically natural or technically synthetic is much less interesting than whether the formula works. We wanted to build from that position.
The third was the texture of the category. Skincare has become anxiety. Multi-step routines, conflicting trend cycles, fear-based marketing about aging. None of that felt good to participate in. We wanted to build something that felt calm and considered, the way a good apothecary feels — science-led, not panic-led.
What Elelaf is
Three product lines, each built around a specific scientific territory rather than a marketing theme.
The Microbiome Glow Serum is built around the skin microbiome — the community of bacteria, fungi, and other microorganisms that live on your skin and affect how it functions. This is no longer fringe science. The 2026 dermatological consensus is that skin health depends on microbial balance, and that the products that disrupt that balance (over-cleansing, aggressive actives stacked on aggressive actives) are part of why so many people’s skin has gotten worse rather than better.
The BioCell Renewal Cream is built around regenerative skincare — peptides, PDRN, and supportive actives that signal cellular repair and collagen synthesis. This is the category dermatology calls “cellular” or “regenerative.” It’s where the most interesting biotech work is happening.
The Mindful Masks are built around the cortisol-skin axis. Chronic stress measurably impairs barrier function and accelerates visible aging. A ten-minute pause that lowers cortisol is doing real work on the skin, on top of whatever the actives are doing.
Each line is formulated to meet US FDA cosmetic regulations and is manufactured in South Korea, where the most innovative skincare R&D happens right now.
What we’re not
We aren’t a “clean beauty” brand. Some of our ingredients are synthetic. Some are natural. We pick what works.
We aren’t a ten-step routine brand. The opposite — we believe most people benefit from four or five products consistently used.
We aren’t promising transformation. We’re promising consistent improvement over months for people who actually use the products properly.
We aren’t anti-anyone. The industry is full of brands doing good work in different lanes. We’re filling a specific niche we noticed, not trying to displace anyone else.
Why FDA compliance and Korean manufacturing both matter
Most brands don’t talk about regulatory standards because the conversation is dull. We talk about it because it affects product quality.
US FDA compliance means our ingredient quality follows US safety standards, our manufacturing follows good manufacturing practices, our labeling is honest about what’s in the bottle, and we’re on the hook for adverse event reporting. That’s real consumer protection.
Korean manufacturing means we get access to the world’s most innovative formulation ecosystem. The cost-effective quality, the access to ingredients like PDRN and postbiotics and modern fermented actives — those are harder to formulate at the same level elsewhere.
The combination — Korean lab innovation, US regulatory baseline — is the position we wanted to build from.
What we want for our readers
Two things matter.
First, that you understand your skin better. Skincare is empowering when you know what’s actually happening and what each product is doing. It’s overwhelming when it’s all marketing claims. The Elelaf Journal exists for understanding, not just selling. Most of what we publish doesn’t try to point you at our products.
Second, that you have a sustainable routine. Three products used consistently outperform twelve products used inconsistently. The minimum viable routine is enough for most people, and most of the time, the right answer is to do less, more carefully.
We sell skincare and we publish education. Both serve the same goal: skin that feels and looks better, with less anxiety attached to the process.
What we believe in 2026
A few positions, since you’ll read them in our pieces anyway. The microbiome is foundational, not a marketing trend. Regenerative biotech matters — peptides, PDRN, exosomes, EGF genuinely work when formulated well. Mindfulness affects skin; the cortisol-skin axis is well-documented. Skinimalism beats maximalism — most people benefit from four or five products consistently used, not ten or twelve in constant rotation. Cultural standards are shifting; the anti-aging panic of the 2010s is fading, and good riddance. Personalization is coming slowly — skin DNA testing, AI analysis, customized formulations. We’re paying attention.
Our manufacturing principles
Effective at evidence-based concentrations, not trace amounts of marketed ingredients. Stable formulations that work when applied. Tested across skin tones, which sounds obvious and isn’t standard. Pregnancy-safe alternatives where applicable. Cosmetically elegant. Pricing that’s accessible. We aren’t luxury positioning — we’re effective accessible skincare.
On trust
We launched understanding that consumers are increasingly skeptical of marketing claims, and they should be. Building trust requires real ingredient lists, real concentration claims, real expectations. Education that exists before the products do, and that we’d publish whether or not it converted to sales. Honest mistakes — we’ll make them, and we’ll address them publicly when they happen. And listening, especially to people who don’t love what we make. The criticism is where the next version comes from.
What’s next
The three hero products are the first; concern-specific products will follow. The Journal will keep publishing five to ten pieces a week. The community side — newsletter, Reddit, Q&A sessions — we’re building deliberately rather than rushing. Refillable packaging, sustainability disclosure, and ethical sourcing transparency are in the works because customers ask for them and they’re right anyway. And we’re building tools — skin assessment, ingredient checker, routine builder — because that’s where editorial meets utility.
We’d rather be small and excellent than large and mediocre. That’s the plan.
A personal note
I’m not a chemist. I’m not a dermatologist. I’m a founder who saw a gap and decided to build something. Our team includes the people whose expertise I don’t have — formulators, dermatologists, skincare scientists — and their work is what makes our products work. What I bring is conviction about what we’re trying to do and why.
That conviction came from watching skincare go in directions I didn’t think served people well. Too many products. Too much fear. Too little science that anyone could read without a chemistry degree. The work, for us, is in building something different.
If the products work for you, we’re glad. If they don’t, we want to hear about it. Feedback is how we get better, and we plan on getting better for a long time.
This is the start.
—Khabir Uddin, Founder
FAQ
Why skincare specifically? Product development background, observation of a gap, and personal interest in the science.
How do I know your products will work? Try them. We have transparent ingredient lists, evidence-based formulations, and a thirty-day return policy.
Are you a small brand or part of a larger conglomerate? Independent and founder-led. Small team, committed.
Can I trust the dermatology claims in your articles? Our science pieces are reviewed by a retained board-certified dermatologist, and we cite peer-reviewed sources.
What’s your long-term vision? Becoming the most trusted brand for considered, mindful consumers who want effective products without the anxiety marketing.
A note from Khabir Uddin, founder of Elelaf. May 2026.
Keep reading
Keep reading
- Behind the BrandWhy FDA approval matters for skincare
- Behind the Brandhow FDA approval works for skincare
- Microbiome StoriesHow to build microbiome resilience in 30 days
Related: The stop-touching-your-face challenge: a 30-day behavioral skin diary.
References
- Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011. PubMed.
- Yu Y, Dunaway S, Champer J, et al.. Changing our microbiome: probiotics in dermatology. Br J Dermatol. 2020. PubMed.
Have a question about “Founder’s notes: why I started Elelaf”?
Ask our editorial desk. Best questions become full follow-up articles, reviewed by our medical reviewer. No medical advice given in private — answers run as articles or not at all.